FDA Approves Pfizer Booster For 12-15 Year Olds, Dismisses Risk Of “Mild” Heart Inflammation
source: zerohedge By: Tyler Durden Monday, January 3, 2022 As expected, the FDA has finally approved Pfizer’s COVID booster for children between the ages of 12 and 15, despite the fact that certain dangerous side effects are far more likely to occur in young patients. These dangerous side effects include myocarditis and pericarditis, two … Continue reading FDA Approves Pfizer Booster For 12-15 Year Olds, Dismisses Risk Of “Mild” Heart Inflammation
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed